Administration of human FSH (hFSH) to cyclic rats during the dioestrous phase attenuates progesterone receptor (PR)-dependent events of the preovulatory LH surge in pro-oestrus. The increased bioactivity of the putative ovarian gonadotropin surge inhibiting/attenuating factor induced by hFSH treatment is not associated with a decrease in PR protein expression, and the possibility of its association at a PR posttranslational effect has been raised. The present experiments aimed to analyse PR phosphorylation status in the gonadotrope of rats with impaired LH secretion induced by in vivo hFSH injection. Two experimental approaches were used. First, incubated pro-oestrous pituitaries from hFSH-injected cycling and oestrogen-treated ovariectomized (OVX) rats were used to analyze the effect of calyculin, an inhibitor of intracellular phosphatases, on PR-dependent LH release, which was measured in the incubation medium by RIA. Second, pituitaries taken from hFSH-injected intact cycling and OVX rats and later incubated with P or GNRH1 were used to assess the phosphorylation rate of gonadotrope. The latter was analysed in formalin-fixed, paraffin-embedded tissue sections by immunohistochemistry using a MAB that recognizes the phosphorylated (p) form of PR at Ser294. Calyculin reduced the ovary-mediated inhibition of hFSH in GNRH1-stimulated LH secretion. In addition, the immunohistochemical expression of pSer294 PR was significantly reduced after ovarian stimulation with hFSH in pituitaries from pro-oestrous rats incubated with P or GNRH1. Altogether, these results suggested that the ovarian-dependent inhibitory effect of FSH injection on the preovulatory LH secretion in the rat may involve an increase in dephosphorylation of PR.
Introduction
In the rat, exogenous FSH increases and/or prolongs the bioactivity (secretion and/or action) of putative gonadotropin surge inhibiting/attenuating factor (GnSI/AF; de Koning 1995 , Fowler et al. 2003 , Messinis 2006 ), a nonsteroidal and non-inhibin ovarian factor (Fowler et al. 1993 , 2003 , Byrne et al. 1995 . GnSI/AF negatively regulates GNRH1-stimulated LH secretion (Tijssen et al. 1997 ) and GNRH1 self-priming (Koppenaal et al. 1991 , Fink 1995 . These two events depend on gonadotrope progesterone receptor (PR; Chappell et al. 1999 , Gordon et al. 2008 .
The mechanism of action of GnSI/AF is largely unknown , Messinis 2006 , although some data are available. Thus, GnSI/AF neutralizes downstream actions of second messengers involved in GNRH1 selfpriming , Tijssen et al. 1997 , and this action is associated with a blockade of gonadotrope PR action (Byrne et al. 1996) rather than with an inhibition of PR expression (Gordon et al. 2008) . The findings reported by Gordon et al. (2008) also suggest that the inhibitory influence of GnSI/AF on preovulatory LH secretion is exerted at gonadotrope PR posttranslational level. Phosphorylation is a posttranslational modification known to modulate the activity of the hormone-activated transcription factor PR (Denner et al. 1990 , Faus & Haendler 2006 ), which appears to occur at serine (Ser) residues exclusively (Beck et al. 1992 , Takimoto & Horwitz 1993 .
Former studies from our group had shown that membrane oestrogen receptor-initiated intracellular signalling enhances gonadotrope protein phosphatase activity and results in the inhibition of GNRH1 selfpriming (Sánchez-Criado et al. 2006 , Garrido-Gracia et al. 2007 . The aim of the present study was to analyse PR phosphorylation status in the gonadotrope of rats with impaired LH secretion induced by GnSI/AF. For this purpose, the biological activity of endogenous GnSI/AF was first increased in cycling rats by the administration of FSH (Geiger et al. 1980 , Koppenaal et al. 1991 , Culler 1992 . Then, pro-oestrous pituitaries from these rats were used to analyse the following: first, the in vitro effect of calyculin, a potent inhibitor of intracellular phosphatases (Condrescu et al. 1999) , on GNRH1-stimulated LH secretion and GNRH1 self-priming, and second, the in vitro effect of ligand-dependent and -independent activators of PR on the immunohistochemical (IHC) expression of PR phosphorylated at the Ser residues level.
Results
Effects of human FSH (hFSH) treatment on vaginal cytology, uterine ballooning and serum 17b-oestradiol (E 2 ) concentration in intact cycling and OVXCoestradiol benzoate (EB) rats Details of the incubation protocols used are given in the Materials and Methods and summarized Fig. 1 . On day 4, vaginal smears from intact cycling and OVXCEB rats treated or not with hFSH displayed nuclear epithelial/ cornified cells characteristic of vaginal pro-oestrus. Also, uteri were ballooned to a similar extent in all four groups of rats. However, differences in E 2 serum concentrations were noted. Whereas treatment with hFSH increased significantly serum E 2 levels in intact cycling rats, treatment with hFSH did not increase serum E 2 concentrations in OVXCEB rats (Fig. 2) .
Effects of hFSH treatment on GNRH1-, phorbol 12-myristate 13-acetate (PMA)-, forskolin (FSK)-, calyculin A-and ionomycin-induced LH secretion in intact cycling and OVXCEB rat pituitaries Pituitaries from pro-oestrous cycling rats injected with saline exhibited increased LH secretion in response to GNRH1; GNRH1 self-priming; and PMA, FSK and calyculin potentiation of GNRH1-stimulated LH secretion (Fig. 3) . In contrast, pituitaries from intact cycling rats treated with hFSH did not display a significant increase in LH secretion in response to GNRH1, PMA and FSK with respect to LH secretion from pituitaries incubated with medium alone. Calyculin at the dose of 10 K7 M significantly increased GNRH1 pituitary responsiveness in pituitaries from hFSH-treated intact cycling rats (Fig. 3) . Moreover, this increasing effect of calyculin on GNRH1-stimulated LH secretion was demonstrated to be dose-dependent (Fig. 4) . The addition of the Ca CC ionophore ionomycin to the incubation medium resulted in a massive release of LH in pituitaries from cyclic rats injected with saline but not in pituitaries from cyclic rats injected with hFSH. No differences were found in LH secretion between calyculinCGNRH1 and ionomycin in intact cycling rats treated or not with hFSH. No differences for any LH secretion parameter were noted on day 4 between pituitaries from OVXCEB rats whether or not treated with hFSH (Fig. 3) .
Effect of hFSH treatment on pituitary LH content in intact cycling and OVXCEB rats
Treatment with hFSH decreased pro-oestrous pituitary LH content in intact cycling rats. This inhibitory effect of hFSH on pituitary LH content was not observed in OVXCEB rats on day 4 (Fig. 5) .
Effect of FSH treatment on pituitary PR10A9 expression in intact cycling and OVXCEB rats
No significant effect of hFSH was found in the number of PR10A9-positive cells in either intact cyclic or OVXCEB rats (Figs 2 and 6A ). The number of PR10A9-positive Figure 1 Diagram showing the pituitary incubation protocol used in each of the four groups of rats: intact cyclingCsaline or hFSH, ovariectomized (OVX)Coestradiol benzoate (EB)Csaline or hFSH (see the Materials and Methods section for details of treatments). After 1 h of pre-incubation with medium (M) alone, hemipituitaries from the four groups of rats were incubated for a 75-min period. Medium accumulation of LH during the last 15 min of the 75-min incubation period (arrow) was used to determine (A) basal LH secretion, (B) GNRH1-stimulated LH secretion, (C) GNRH1 selfpriming, (D) PRKCC potentiation of GNRH1-stimulated LH secretion, (E) PRKACA potentiation of GNRH1-stimulated LH secretion, (F) calyculin A (calyc) effect on GNRH1-stimulated LH secretion and (G) Ca pituitary cells in OVXCEB rats was significantly higher than that in intact cycling rats (Fig. 2) . A high correlation (rZ0.987; yZ0.01xC8.91) was found between serum E 2 concentrations and the number of PR10A9-positive pituitary cells.
Pituitary pSer294 expression in pro-oestrous cycling rats
Immunoreactive products to pSer294 MAB, diluted 1:300, were observed in the nuclei of some pituitary cells (Fig. 6 ). The number of pSer294-positive cells was higher in pituitaries incubated for 1 or 2 h either with P or GNRH1 than in those incubated with medium alone (Figs 6B and 7) . This effect, which was more evident in pituitaries incubated with the cognate ligand (the effect of P was about threefold higher than that of GNRH1), was demonstrated to be dose dependent (Fig. 7) .
Effect of hFSH treatment on P-and GNRH1-induced pSer294 expression in intact cycling and in OVXCEB rat pituitaries
The number of cells expressing pSer294 was significantly reduced in pituitaries from hFSH-treated cycling rats incubated either with P or GNRH1. In contrast, the number of gonadotropes expressing pSer294 was not affected by hFSH in OVXCEB rats injected regardless of incubation conditions (Fig. 8 ).
Discussion
The results of the present study showed that the putative ovarian GnSI/AF action on PR-dependent LH secretion in pro-oestrous rats was associated with an increase in gonadotrope PR dephosphorylation. In physiological conditions, the bioactivity of GnSI/AF is expressed in dioestrus (Tijssen et al. 1997 ), but it is prolonged up to pro-oestrus under the influence of exogenous FSH 
FSH reduces LH secretion and PR phosphorylation
(present results). These facts are in agreement with previous results showing that the decrease in serum FSH concentration during dioestrus reduces and/or shortens GnSI/AF bioactivity and advances the preovulatory LH release in cyclic rats by 1 day (Tebar et al. 1998) . Overall, the present results suggested that PR dephosphorylation was involved in the ovary-mediated FSH inhibitory effect on GNRH1-stimulated LH secretion (Tijssen et al. 1997) .
The inhibitor of intracellular phosphatases calyculin sensitized only in part the incubated pituitaries from intact cycling pro-oestrous rats injected with hFSH to the releasing action of GNRH1. In contrast, calyculin fully primed the incubated pituitaries collected from saline-injected intact cycling pro-oestrous rats, as well as those collected from OVXCEB rats, to the releasing action of GNRH1 regardless of whether they were treated or not with hFSH. Pituitaries collected from pro-oestrous rats treated with hFSH had low pituitary responsiveness to well-known secretagogue and priming phosphorylating agents (GNRH1, PRKCC and PRKACA). This was also observed in a previous report from our laboratory in which the potentiating effect of the cognate phosphorylating ligand P on GNRH1-stimulated LH secretion was found to be absent in hFSH-treated cyclic rats (Gordon et al. 2008) . OVX reversed all inhibitory actions of hFSH on gonadotrope function (Gordon et al. 2008, present results) . This effect of OVX indicated that the inhibitory effects of hFSH on LH secretion were mediated by an ovarian factor (de Koning et al. 1987 , Balen 1996 that was found to be non-steroidal in nature (Fowler et al. 2003 , Messinis 2006 . As calyculin inhibits phosphatase-induced dephosphorylation, these findings seemed to indicate that the putative GnSI/AF produces an imbalance of phosphorylase/phosphatase activities on gonadotrope PR, limiting the magnitude of the PR-dependent LH secretion. In addition, lower LH synthesis may also exist in intact cycling rats injected with hFSH. This is because treatment with hFSH reduced pituitary LH content in intact cycling rats but not in OVX rats. Furthermore, the Ca CC ionophore ionomycin induced, as expected, a vast LH exocytosis in pituitaries from all experimental groups, except for pituitaries from intact cycling rats given hFSH, in which LH exocytosis was only modest.
In rats injected with hFSH, non-steroidal ovarian substances inhibin (Ying 1988) and GnSI/AF (Messinis 2006) are ovarian factors probably involved in the attenuation of the preovulatory LH surge (Culler 1992) . However, accumulated evidence indicates that GnSI/AF is different from inhibin in many respects (Scott & Burger 1981 , de Koning et al. 1987 , Balen et al. 1995 , Fowler et al. 2003 . In this regard, the findings by Ishigame et al. (2004) are of interest because they show attenuated LH surges in rats after ovarian stimulation with FSH in the absence of bioactive inhibin. As a matter of fact, the negative feedback of ovarian inhibin on FSH release is via interaction with a specific receptor at the gonadotrope membrane ( Robertson et al. 2000) , and involves inhibition of both secretion and synthesis of FSH (Scott & Burger 1981 , Attardi et al. 1991 . Similarly, the GnSI/AF acting on specific gonadotrope membrane receptors different from GNRH1 receptors reduced preovulatory LH secretion and pituitary LH synthesis.
The balance between the activities of protein kinases and phosphatases ) is the most common posttranslational processing event of PR (Faus & Haendler 2006) . Thus, phosphorylation seemed to be involved in PR-regulated gene transcription (Denner et al. 1990 . Studies on PR (Beck et al. 1992 (Beck et al. , 1996 indicate that only Ser residues are phosphorylated (Takimoto & Horwitz 1993) , and that Ser294 phosphorylation is strongly hormone dependent ). The cognate agonist and the intracellular messengers of GNRH1 (Denner et al. 1990 , Bai et al. 1997 ) phosphorylate Ser294 and induce PR-mediated transcription (Zhang et al. 1994) , expression of PR-dependent GNRH1 self-priming proteins (Fink 1995 , Tijssen et al. 1997 , preovulatory LH secretion (Fink 1988 ; Fig. 9 ) and PR down-regulation (Lange et al. 2000) . We have standardized the IHC method for the detection of PR with a phosphorylated Ser residue at position 294 in rat pituitaries. The antibody pSer294 recognizes the immunogen corresponding to 
amino acid residues 288-300 from human PR with Ser294 being phosphorylated, P(288)MAPGRS(p)PLATTV(300) (Clemm et al. 2007) . PR alignment revealed an almost full-sequence homology of amino acid residues between the human immunogen and rat PR: P(286)-VAPGRSPLATTV(298). The effect of different phosphorylating agents on incubated pituitaries was expressed as the percentage of PR (PR10A9)-positive pituitary cells expressing pSer294 immunoreactive products. In the rat, gonadotropes are the only pituitary cell type expressing PR (Fox et al. 1990 , Turgeon & Waring 2000 , Sánchez-Criado et al. 2004 , and the present experiments showed a high correlation between E 2 serum levels and the number of pituitary PR10A9 immunoreactive cells. Our results also showed that gonadotropes exhibited a low PR phosphorylation rate (pSer294 expression) in the absence of P or GNRH1 in the incubation medium, while both P and GNRH1 induced pSer294 immunoreactivity in a dose-and time-dependent manner. This ligand-dependent and -independent phosphorylation of gonadotrope PR was significantly reduced in pituitaries from rats undergoing the ovary-mediated inhibitory action of hFSH. Similarly, it has been shown that treatment with alkaline phosphatases inhibits PR phosphorylation in T47D cells (Takimoto & Horwitz 1993) . Finally, PR is expressed as two isoforms: PR-A and PR-B (Kastner et al. 1990 ). While PR-B is the stronger transcriptional activator isoform of PR, PR-A is a modulatory isoform of PR-B action (Kazmi et al. 1993) .
As the antibody pSer294 has preferential affinity for PR-B , results of the present study suggest that the deficient phosphorylation/ activation of PR-B isoform could be a probable causative factor of the ovary-mediated hFSH-induced attenuation of LH secretion (Fig. 9 ).
In conclusion, the results suggested that the inhibitory effect of the FSH-dependent putative ovarian bioactive GnSI/AF on the preovulatory LH secretion in the rat may be due to dephosphorylation of gonadotrope PR.
Materials and Methods

Animals
General conditions and surgery
Adult female Wistar rats weighing 190-210 g were housed under a 14 h light:10 h darkness cycle (lights on at 0500 h) and 22G2 8C room temperature, with access to rat chow and tap water ad libitum. Rats were included in the experiments after showing at least three consecutive 4-day regular oestrous cycles. Vaginal smears were taken 6 days/week and the day of vaginal oestrus was arbitrarily considered as day 1. Bilateral ovariectomy (OVX) was performed under light ether anaesthesia at 0900 h on day 2 of the cycle. Rats were decapitated at 0900 h on day 4; their a P!0.05 intact cycling rats injected with saline. Figure 9 Schematic showing the proposed interrelationship of the cellular and molecular components that may be involved in the regulation of progesterone receptor (PR) activity and LH release. At the pituitary level, E 2 activates nuclear (n) ESR1 and nESR2 which, in addition to many other priming effects, induces PR expression. These PR become activated/phosphorylated by P and/or the E 2 -dependent GNRH1-intracellular messengers PRKCC and PRKACA. Also at the pituitary level, E 2 activates gonadotrope membrane (m) ESR1, which increases intracellular phosphatases activity. The latter can also be activated by GnSI/AF (present paper). The balance between intracellular kinases and phosphatases activities elicits PR-dependent transcription of priming proteins, GNRH1 self-priming and LH surge.
pituitary glands removed, separated from the neural lobe, divided in halves and assigned to incubation, pituitary LH content or IHC studies. All experimental protocols were approved by the Ethical Committee of the University of Córdoba, and experiments were performed in accordance with rules on laboratory animal care and international law on animal experimentation.
Treatment with hFSH
Recombinant hFSH (Gonal-f; Serone, Aubonne, Switzerland) was dissolved at a concentration of 50 IU/ml saline and 10 IU hFSH was given s.c. at 1400 h on day 2 and at 0900 h on day 3 (Gordon et al. 2008) . This dose of hFSH derives from the results of previous experiments (Gordon et al. 2008) . Non-stimulated controls were given 0.2 ml saline. Groups of rats treated with hFSH included intact cycling rats (intact cyclingChFSH) and ovariectomized (OVX) rats treated with EB (OVXCEBChFSH). OVX rats were given 5 and 10 mg EB/0.2 ml oil at 1400 h on day 2 and at 0900 h on day 3 respectively (Schuiling et al. 1999) .
Rat pituitary incubation studies
General incubation protocol of rat pituitaries
Incubation of pituitaries was carried out, with minor modifications, as described previously (Gordon et al. 2008) . Briefly, hemipituitaries were divided into quarters (Knox & Schwartz 1993 ) and incubated at 37 8C with constant shaking (60 cycles/min) in an atmosphere of 95% O 2 and 5% CO 2 . Each incubation vial contained 250 ml Dulbecco's modified medium without L-glutamine and phenol red and containing glucose (4.5 g/l), 10
K8 M E 2 (Sigma Chemical Co.) and BSA (0.1% w/v, pH 7.4). After 1-h pre-incubation without test substances, hemipituitaries were incubated for 75 min with different test substances (Fig. 1) . In the last 15 min, the medium was removed for the determination of LH concentration and pituitary responsiveness (Fig. 1) . Doses of hormones and drugs used and timing of treatments derive from previous papers (Denner et al. 1990 , Turgeon & Waring 1991 , Sánchez-Criado et al. 2004 , 2006 , Gordon et al. 2008 .
Effects of hFSH treatment on GNRH1-, PMA-, FSK-, calyculin A-and ionomycin-induced LH secretion in intact cycling and OVXCEB rat pituitaries
Hemipituitaries of the four groups of animals (intact cycling
ChFSH, intact cyclingCsaline, OVXCEBChFSH and OVX CEBCsaline) were incubated (see general incubation protocol) with different test substances (Fig. 1) . Test substances included were: 10 K8 M GNRH1 (Peninsula 7201, Peninsula Lab. Inc., Merseyside, UK), 10 K7 M of the PRKCC activator PMA (Sigma), 5!10 K5 M of the activator of adenylyl cyclase FSK (Sigma) and 10 K7 M calyculin A (Sigma), an inhibitor of intracellular phosphatases (Marantz et al. 1995 , Condrescu et al. 1999 . Whereas PMA, FSK and calyculin A were present during the entire 75-min incubation period, GNRH1 challenge was present during the first 15 min only (Fig. 1) . Except for hemipituitaries incubated with medium alone and ionomycin, fresh medium containing the corresponding test substance (medium, PMA, FSK or calyculin) plus GNRH1 was added during the last 15-min period. Finally, to evaluate the secretory capacity of the gonadotropes, hemipituitaries from intact cyclingCsaline, intact cyclingChFSH, OVXCEBCsaline and OVXCEBChFSH rats were incubated with 5!10 K5 M of the ionophore ionomycin (Sigma) during the 75-min incubation period. Additional hemipituitaries from the four experimental groups of rats were incubated in the presence of increasing doses of calyculin (0, 10
K8
, 10 K7 and 10 K6 M) during the 75-min incubation period and challenged with GNRH1 during the last 15 min of incubation. Values in this last experiment were expressed as the percentage of LH release from controls (pituitary LH release from cyclic or OVXCEB rats injected with saline).
Concentrations of LH in incubation media were measured in duplicate by RIA using a double-antibody method with kits supplied by NIH (Bethesda, MD, USA) and a previously described microassay method (Sánchez-Criado et al. 1990 , Garrido-Gracia et al. 2007 . Rat LH-I-10 was labelled with 125 I by the chloramine-T method (Greenwood et al. 1963) . All media samples were assayed in the same test. The intra-assay coefficients of variation were 8%. Assay sensitivity was 3.75 pg/tube. Results are expressed as ng/hemipituitary of the RP LH-rat-RP-3.
Effect of hFSH treatment on anterior pituitary LH content and E 2 serum levels
Anterior pituitaries from the four groups of animals were obtained at 0900 h on day 4 to evaluate the LH content by RIA and the protein content by the Bradford method (Bradford 1976 ) using the Quick Start Bradford protein assay (Bio-Rad Laboratories, Inc). Trunk blood was obtained from these rats, allowed to clot, centrifuged and the serum stored at K20 8C until quantified for E 2 . Pituitary LH content was measured in duplicate by the RIA method described above. Results are expressed as mg/mg pituitary protein.
Serum E 2 concentrations were determined in duplicate using a commercially obtained kit (Abbott Diagnostic Division). The sensitivity of the assay was 10 pg/ml, and the intra-assay coefficient of variation was 7%. E 2 concentrations were expressed as pmol/l serum.
IHC studies of the PR phosphorylation status in rat pituitaries
IHC expression of PR in gonadotropes
The commercial mouse monoclonal anti-human PR antibody (PR10A9), raised against the recombinant hormone-binding domain of human PR located in the C-terminal domain (Kastner et al. 1990 ) of PR (Immunotech, Marseille, France), diluted 1:15 000, was analysed using the avidin-biotinperoxidase complex (ABC) IHC method as described elsewhere (Sánchez-Criado et al. 2004 , 2006 , Gordon et al. 2008 . The number of cells immunoreactive to PR10A9 antibody was determined by counting all positive nuclei in 8-15 fields at a magnification of 40! (high-power field, HPF) per tissue section and expressed as the number of positive nuclei/HPF. Four consecutive tissue sections were immunostained and counted per pituitary. The commercial mouse monoclonal phospho-PR (pSer294) antibody clone 608, raised against the immunogen P(288)MAPGRS(p)PLATTV(300) located in the N-terminal domain (Affinity BioReagents, Golden, CO, USA), diluted 1:300, was analysed using the ABC IHC technique (Vectastain, ABC kit Elite, Vector Corporation, Burlingame, CA, USA). This method was standardized in formalin-fixed, paraffin-embedded pituitary tissue sections from rats in pro-oestrus under phosphorylating conditions. For this purpose, three pituitaries/group from pro-oestrous cycling rats were incubated over 1 or 2 h with medium alone or with 10 K7 and 10 K6 M P (ligand-dependent activator of PR) or 10 K8 and 10 K7 M GNRH1 (ligandindependent activator of PR). Three additional pituitaries were incubated with medium alone as PR phosphorylation negative controls. Three different dilutions of pSer294 antibody were assayed, 1:100, 1:300 and 1:500, and the final working dilution of 1:300 was selected on the basis of the quality and specificity of immunostaining (Fig. 6) . Briefly, dewaxed and rehydrated 3 mm thick tissue sections were subjected to high-temperature antigen retrieval by incubation with 0.01 M citrate buffer (pH 6.0) at 95 8C for 8 min in a decloaking chamber (Biocare Medical, Concord, CA, USA). All further IHC staining procedures were according to the test kit instructions. Tissue sections were counterstained with Mayer's hematoxylin. The substitution of specific primary antibody with non-immune mouse IgG 1 (Affinity Bioreagents) in tissue sections of the pituitaries under study were used as negative control in every assay.
Effect of hFSH treatment on the IHC expression of phosphorylated PR (phospho-PR-pSer294) in gonadotropes
Three pituitaries from each of the four experimental groups of rats were incubated for 2 h with 10 K6 M P, 10 K7 M GNRH1 or medium alone. Concentrations and incubation times of P and GNRH1 were selected on the basis of the IHQ standardization protocol results.
The number of cells immunoreactive to pSer294 antibody was determined similarly than PR10A9 antibody. The number of PR phosphorylated at pSer294 was expressed as the number of phosphorylated PR at Ser294 (pSer294-positive cells)/number of PR-positive gonadotropes (PR10A9-positive cells)!100. Eight consecutive tissue sections were immunostained and counted per pituitary (even for PR10A9 and odd for pSer294).
Statistical analysis
Statistical analysis was performed by ANOVA to test for significant differences among groups. When significant differences existed, ANOVA was followed by the StudentNewman-Keuls multiple range test to compare the means. Significance was considered at the 0.05 level.
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